In this webcast from the ‘New Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Drs. James R. Berenson, Adam D. Cohen, Deepu Madduri, and Sham Mailankody discuss the current and future state of CAR-T therapy for myeloma patients. © 2019 Imedex, an HMP Company
Ruxolitinib Is Under Investigation as JAK Inhibition Strategy for Multiple Myeloma
CancerNetwork® spoke with James R. Berenson, MD, founder, medical and scientific director, and president and chief...